Research Article

Construction of a Cuproptosis-Related lncRNA Prognostic Model for Bladder Urothelial Carcinoma and Screening of Potential Drugs

Table 4

Screening of differential risk genes (partial examples).

GeneLow meanHigh meanlogFC-valuefdr

FER1L447.1938198812.700754−1.8936837
AL390719.214.747140354.6966788−1.6507224
AL450384.23.3484027290.8479688−1.9813899
RAD51-AS13.9055678361.8979207−1.0411126
ZNF436-AS12.0653824560.8775648−1.2348314
SH3BP5-AS11.7074116960.7326129−1.2206880
LINC026045.8982937622.7048577−1.1247450
AP002026.11.7949428850.5660923−1.6648288
PPFIBP214.229308775.1865937−1.4560063
LINC009303.6422306040.6977504−2.3840394